BAA pmqwp#187 "new analytical methods for complex sameness of injectable, long-acting plga formulations"

Ended Definitive Contract Awarded Last action

Contract number
75F40119C10096
Awardee
Awarding agency
Obligated
$992,305

Award facts

Opportunity
  • FDABAA1900123 Solicitation number
Contract value 100% obligated
$992,304.63 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
West Lafayette, IN, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $264,187
Original award $728,118

About this award

This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Akina, Inc., a minority-owned, for-profit Asian-Pacific American manufacturer, for the development of "NEW ANALYTICAL METHODS FOR COMPLEX SAMENESS OF INJECTABLE, LONG-ACTING PLGA FORMULATIONS" under Broad Agency Announcement (BAA) PMQWP#187. The contract, with a firm fixed price of $992,304.63, was awarded on September 25, 2019, and has a completion date of September 29, 2022. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75F40119C10096?

75F40119C10096 was awarded to Akina, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 25, 2019.

How much is contract 75F40119C10096 worth?

The government has obligated $992,305 on 75F40119C10096.

Was contract 75F40119C10096 competed?

The extent of competition for 75F40119C10096 was full and open competition. The government received 11 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award